FindMyRecallSubscribe
Class II: temporary or reversible health riskCompleted

Amneal Pharmaceuticals of New York Methylergonovine Maleate Tablets Recall

Methylergonovine Maleate Tablets, USP, 0

Amneal Pharmaceuticals of New York, LLC · Brookhaven, NY

Risk level
Class II
Reported by FDA
May 8, 2024
Recall ID
D-0477-2024
Check your lot numberHow we source this data

Summary

Amneal Pharmaceuticals of New York recalled Methylergonovine Maleate Tablets starting Mar 25, 2024. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0477-2024 on May 8, 2024. Reason: Failed Dissolution Specifications. Status: Completed.

Why it was recalled

Failed Dissolution Specifications

Product description

Methylergonovine Maleate Tablets, USP, 0.2mg, 12-count bottle, Rx Only, Distributed by: Amneal Pharmaceuticals, LLC, Bridgewater, NJ 08807, NDC # 69238-1605-2.

Lot numbers, UPCs & expiration codes

Lot #: BJ01922A, exp. date 03/2024

Where it was sold

US Nationwide.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0477-2024
Classification
Class II
Status
Completed
Recall initiated
Mar 25, 2024
FDA report date
May 8, 2024
Quantity
2784 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Amneal Pharmaceuticals of New York, LLC

Original FDA data

Every field from FDA enforcement report D-0477-2024, exactly as published.

Show all FDA fields
City
Brookhaven
State
NY
Status
Completed
Country
United States
Event ID
94286
Address
50 Horseblock Rd
Code information
Lot #: BJ01922A, exp. date 03/2024
Postal code
11719-9509
Report date
May 8, 2024
Product type
Drugs
Recall number
D-0477-2024
Classification
Class II
Recalling firm
Amneal Pharmaceuticals of New York, LLC
Product quantity
2784 bottles
Reason for recall
Failed Dissolution Specifications
Voluntary / mandated
Voluntary: Firm initiated
Product description
Methylergonovine Maleate Tablets, USP, 0.2mg, 12-count bottle, Rx Only, Distributed by: Amneal Pharmaceuticals, LLC, Bridgewater, NJ 08807, NDC # 69238-1605-2.
Distribution pattern
US Nationwide.
Recall initiation date
Mar 25, 2024
Initial firm notification
Letter
Center classification date
Apr 29, 2024

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0477-2024, published May 8, 2024. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls